Trial Information

Summary: Phase IV - Alzheimer's Disease Once-a-day Patch Medication, Trial Study

This study aims to test the efficacy of a new method of administering the Alzheimer's disease medication called Exelon. A caregiver or study partner is required. Participants would have to make occasional visits to the Sun Health Research Institute and participate in some cognitive testing and physical evaluation.

Patient Inclusion Criteria:

• Must have a caregiver
• Must have a clinical diagnosis of Alzheimer's disease

Patient Exclusion Criteria: Treatment with any other acetylcholinesterase inhibitors.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:32:47 AM